References
- Z. Wei, Z. Yu and D. Bi, Design and evaluation of a two-layer floating tablet for gastric retention using cisapride as a model drug, Drug Dev. Ind. Pharm. 27 (2001) 469-474; DOI: 10.1081/DDC-100104323.
- S. Arora, J. Ali, A. Ahuja, R. K. Khar and S. Baboota, Floating drug delivery systems: a review, AAPS PharmSciTech. 6 (2005) Article 47; DOI: 10.1208/pt060347.
- Z. Rahman, M. Ali and R. K. Khar, Design and evaluation of bilayer floating tablets of captopril, Acta Pharm. 56 (2006) 49-57.
- R. Talukder and R. Fassihi, Gastroretentive delivery systems: a mini rewiew, Drug Dev. Ind. Pharm. 30 (2004) 1019-1028; DOI: 10.1081/DDC-200040239.
- S. Baumgartner, J. Kristl, F. Vrecer, P. Vodopivec and B. Zorko, Optimisation of floating matrix tablets and evaluation of their gastric residence time, Int. J. Pharm. 195 (2000) 125-135; DOI: 10.1016/SO378-5173(99)00378-6.
- S. Strübing, H. Metz and K. Mader, Characterization of poly(vinyl acetate) based floating matrix tablets, J. Control. Release 126 (2008) 149-155; DOI: 10.1016/j.jconrel.2007.11.013.
- G. Chawla, P. Gupta, V. Korodia and A. K. Bansal, A means to address regional variability in intestinal drug absorption, Pharm. Technol. 27 (2003) 50-68.
- J. Varshosaz, N. Tavakoli and F. Roozbahani, Formulation and in vitro characterization of cipro-floxacin floating and bioadhesive extended-release tablets, Drug Deliv. 13 (2006) 277-285; DOI: 10.1080/10717540500395106.
- M. I. Tadros, Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy human volunteers, Eur. J. Pharm. Biopharm. 74 (2010) 332-339; DOI: 10.1016/j.ejpb.2009.11.010.
- B. N. Singh and K. H. Kim, Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention, J. Control. Release 63 (2000) 235-259; DOI: 10.1016/S0168-3659(99)00204-7.
- N. Özdemir, Ş. Ordu and Y. Özkan, Studies of floating dosage forms of furosemide: in vitro in vivo evaluations of bilayer tablet formulations, Drug Dev. Ind. Pharm. 26 (2000) 857-866; DOI: 10.1081/DDC-100101309.
- United States Pharmacopeia 30/National Formulary 25, USP Convention, Rockville (MD) 2007.
- T. Higuchi, Mechanism of sustained-action medication: theoretical analysis of rate of release of solid drugs dispersed in solid matrices, J. Pharm. Sci. 52 (1963) 1145-1149; DOI: 10.1002/jps.2600521210.
- R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25-35; DOI: 10.1016/0378-5173(83)90064-9.
- N. A. Peppas and J. J. Sahlin, A simple equation for the description of solute release. III: Coupling of diffusion and relaxation, Int. J. Pharm. 57 (1989) 169-172; DOI: 10.1016/0378-5173(89)90306-2.
- S. Sungthongjeen, P. Sriamornsak and S. Puttipipatkhachorn, Design and evaluation of floating multi-layer coated tablets based on gas formation, Eur. J. Pharm. Biopharm. 69 (2008) 255-263; DOI: 10.1016/j.ejpb.2007.09.013.
- P. Colombo, D. Provasi, M. G. Borazza, L. Maggi and P. L. Catellani, The role of compression force in floating tablet formula optimization, Acta Pharm. Technol. 35 (1989) 168-170.
- P. Colombo, R. Bettini and N. A. Peppas, Observation of swelling process and diffusion front position during swelling in hydroxypropyl methylcellulose (HPMC) matrices containing a soluble drug, J. Control. Release 61 (1999) 83-91; DOI: 10.1016/S0168-3659(99)00104-2.
- N. A. Peppas, Analysis of Fickian and non-Fickian drug release from polymers, Pharm. Acta Helv. 60 (1985) 110-111.